Sexually transmitted diseases

Primary Care - Clinics in Office Practice

Volumn 40, Issue 3, 2013, Pages 557-587

  Markle, William ^a,b   Conti, Tracey ^a,b   Kad, Manjusha ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b USA   (United States)

Author keywords

Chancroid; Chlamydia; Genital warts; Gonorrhea; Herpes; Lice; Lymphogranuloma venereum; Syphilis

Indexed keywords

ACICLOVIR; AMOXICILLIN; AZITHROMYCIN; BENZATHINE PENICILLIN; BENZATHINE PENICILLIN PLUS PROCAINE PENICILLIN; CANTHARIDIN; CEFIXIME; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; ERYTHROMYCIN ETHYLSUCCINATE; FAMCICLOVIR; GREEN TEA EXTRACT; IMIQUIMOD; LEVOFLOXACIN; METRONIDAZOLE; OFLOXACIN; PENICILLIN G; PODOPHYLLOTOXIN; POTASSIUM HYDROXIDE; RETINOID; SALICYLIC ACID; SPECTINOMYCIN; TETRACYCLINE; TINIDAZOLE; UNINDEXED DRUG; VALACICLOVIR; WART VIRUS VACCINE;

CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONDOM; CONDYLOMA ACUMINATUM; CRYOTHERAPY; DIAGNOSTIC PROCEDURE; GASTROINTESTINAL SYMPTOM; GENITAL HERPES; GONORRHEA; GRANULOMA INGUINALE; HEALTH EDUCATION; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; INFECTION PREVENTION; LYMPHOGRANULOMA VENEREUM; MOLLUSCUM CONTAGIOSUM; MORBIDITY; NEISSERIA GONORRHOEAE; NEUROSYPHILIS; NONHUMAN; NUCLEIC ACID AMPLIFICATION; PATHOPHYSIOLOGY; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; PROCTITIS; PUBIC PEDICULOSIS; REVIEW; RISK FACTOR; SCREENING; SEXUALLY TRANSMITTED DISEASE; SINGLE DRUG DOSE; SYPHILIS; TRICHOMONAS; TRICHOMONIASIS; ULCUS MOLLE; UNITED STATES; VACCINATION; WART VIRUS;

CHANCROID; CHLAMYDIA; GENITAL WARTS; GONORRHEA; HERPES; LICE; LYMPHOGRANULOMA VENEREUM; SYPHILIS;

ANTI-INFECTIVE AGENTS; COMMUNICABLE DISEASE CONTROL; COST-BENEFIT ANALYSIS; DIAGNOSTIC TECHNIQUES AND PROCEDURES; HOMOSEXUALITY, MALE; HUMANS; INCIDENCE; MALE; MASS SCREENING; PRIMARY HEALTH CARE; RISK FACTORS; SEX FACTORS; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASES; UNITED STATES;

EID: 84882250204     PISSN: 00954543     EISSN: 1558299X     Source Type: Journal    
DOI: 10.1016/j.pop.2013.05.001     Document Type: Review

References (125)

1. Workowski K.A., Levine W.C., Wasserheit J.N. U.S. Centers for Disease Control and Prevention Guidelines for the Treatment of Sexually Transmitted Diseases: an opportunity to unify clinical and public health practice. Ann Intern Med 2002, 137:255-262.
2. CDC STD Trends in the US 2010: National data for Chlamydia, gonorrhea and syphilis 2011, US Department of Health and Human Services, Atlanta (GA), Available at:, Accessed September 3, 2012. http://www.cdc.gov/std/stats10/trends.htm.
3. Decker M.R., Miller E., McCauley H.L., et al. Sex trade among young women attending family-planning clinics in Northern California. Int J Gynaecol Obstet 2012, 117(2):173-177.
4. Maheux B., Haley N., Rivard M., et al. STD risk assessment and risk reduction counseling by recently trained family physicians. Acad Med 1995, 70(8):726-728.
5. Seubert D.E., Thompson I.M., Gonik B. Partner notification of sexually transmitted disease in an obstetric and gynecology setting. Obstet Gynecol 1999, 94:399-402.
6. Weisbord J.S., Koumans E.H., Toomey K.E., et al. Sexually transmitted diseases during pregnancy: screening, diagnostic and treatment practices among prenatal care providers in Georgia. South Med J 2001, 94(1):47-53.
7. Gonzalez J.S., Hendrikson E.S., Collins E.M., et al. Latinos and HIV/AIDS: examining factors related to disparity and identifying opportunities for psychosocial intervention research. AIDS Behav 2009, 13:582-602.
8. DeNavas-Walt C., Proctor B.D., Smith J.C. U.S. Census Bureau, current population reports, P60-238, income, poverty and health insurance coverage in the United States: 2009 2010, US Government Printing Office, Washington, DC.
9. Wiehe S.E., Rosenman M.B., Wang J., et al. Chlamydia screening among young women: individual- and provider-level differences in testing. Pediatrics 2011, 127(2):e336-e344.
10. CDC. Special Focus Profiles: STDs in racial and ethnic minorities. STD Surveillance. 2010. Available at: Accessed September 3, 2012. http://www.cdc.gov/std/stats10/minorities.htm.
11. Forhan S.E., Gottlieb S.L., Sternberg M.R., et al. Prevalence of sexually transmitted infections among female adolescents aged 14-19 in the United States. Pediatrics 2009, 124:1505.
12. Tripp J., Viner R. Sexual health, contraception and teenage pregnancy. BMJ 2005, 330:590-593.
13. Weinstock H., Berman S., Cates W. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspect Sex Reprod Health 2004, 36(1):6-10.
14. Tu W., Batteiger B.E., Wiehe S., et al. Time from first intercourse to first sexually transmitted infection diagnosis among adolescent women. Arch Pediatr Adolesc Med 2009, 163:1106.
15. Burstein G.R., Gaydos C.A., Diener-West M., et al. Incident Chlamydia trachomatis infections among inner-city adolescent females. JAMA 1998, 280:521.
16. Fortenberry J.D. Adolescent substance use and sexually transmitted disease risk: a review. JAdolesc Health 1995, 16:304.
17. Niccolai L.M., Ethier K.A., Kershaw T.S., et al. New sex partner acquisition and sexually transmitted disease risk among adolescent females. JAdolesc Health 2004, 34:216.
18. Thrall J.S., McCloskey L., Ettner S.L., et al. Confidentiality and adolescents' use of providers for health information and for pelvic examinations. Arch Pediatr Adolesc Med 2000, 154:885.
19. Jena A.B., Goldman D.P., Kamdar A., et al. Sexually transmitted diseases among users of erectile dysfunction drugs: analysis of claims data. Ann Intern Med 2010, 153:1-7.
20. Harned M.S., Panatlone D.W., Ward-Ciesielski E.F., et al. The prevalence and correlates of sexual risk behaviors and sexually transmitted infections in outpatients with borderline personality disorder. JNerv Ment Dis 2011, 199:832-838.
21. Low N., Broutet N., Adu-Sarkodie Y., et al. Global control of sexually transmitted infections. Lancet 2006, 368:2001.
22. CDC Sexually transmitted disease surveillance, 2008 2009, US Department of Health and Human Services, Atlanta (GA)
23. Peterman T.A., Tian L.H., Metcalf C.A., et al. High incidence of new sexually transmitted infections in the year following a sexually transmitted infection: a case for rescreening. Ann Intern Med 2006, 145:564.
24. Centers for Disease Control and Prevention Sexually transmitted diseases treatment guidelines, 2010. MMWR 2010, 59(No. RR-12):1-109.
25. Centers for Disease Control and Prevention Sexually transmitted disease, gonorrhea, fact sheet 2013, CDC, Atlanta (GA), Available at:, Accessed June 21, 2013. http://www.cdc.gov/std/gonorrhea/STDFact-gonorrhea.htm.
26. Centers for Disease Control and Prevention Sexually transmitted disease surveillance 2011 2011, US Department of Health and Human Services, Atlanta (GA).
27. Klausner J.D., Barrett D.C., Dithmer D. Risk factors for repeated gonococcal infections: San Francisco, 1990-1992. JInfect Dis 1998, 177:1766.
28. Hook E.W., Reichart C.A., Upchurch D.M., et al. Comparative behavioral epidemiology of gonococcal and chlamydial infections among patients attending aBaltimore, Maryland, sexually transmitted disease clinic. Am J Epidemiol 1992, 136:662.
29. Handsfield H.H., Sparling P.F. Neisseria gonorrhoeae. Principles and practice of infectious diseases 1995, 1909. Churchill Livingstone, New York. 4th edition. G.L. Mandell, J.E. Bennett, R. Dolin (Eds.).
30. Centers for Disease Control and Prevention (CDC) Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections. MMWR 2007, 56:332.
31. Centers for Disease Control and Prevention Update to CDC's sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections. MMWR 2012, 61:590.
32. Datta S.D., Sternberg M., Johnson R.E., et al. Gonorrhea and chlamydia in the United States among persons 14 to 39 years of age, 1999 to 2002. Ann Intern Med 2007, 147:89.
33. Centers for Disease Control and Prevention Expedited partner therapy in the management of sexually transmitted diseases 2006, US Department of Health and Human Services, Atlanta (GA), Available at:, Accessed September 3, 2012. http://www.cdc.gov/std/treatment/EPTFinalReport2006.pdf.
34. Centers for Disease Control and Prevention Sexually transmitted disease, chlamydia, fact sheet 2013, CDC, Atlanta (GA), Available at:, Accessed June 21, 2013. http://www.cdc.gov/std/chlamydia/stdfact-chlamydia.htm.
35. Warszawski J., Meyer L., Weber P. Criteria for selective screening of cervical Chlamydia trachomatis infection in women attending private gynecology practices. Eur J Obstet Gynecol Reprod Biol 1999, 86:5.
36. Gaydos C.A., Howell M.R., Pare B., et al. Chlamydia trachomatis infections in female military recruits. NEngl J Med 1998, 339:739.
37. Phillips R.S., Hanff P.A., Holmes M.D., et al. Chlamydia trachomatis cervical infection in women seeking routine gynecologic care: criteria for selective testing. Am J Med 1989, 86:515.
38. Centers for Disease Control and Prevention Chlamydia trachomatis genital infection-United States, 1995. MMWR Morb Mortal Wkly Rep 1997, 46(9):193-198.
39. Geisler W.M. Diagnosis and management of uncomplicated Chlamydia trachomatis infections in adolescents and adults: summary of evidence reviewed for the 2010 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines. Clin Infect Dis 2011, 53(Suppl 3):S92.
40. Lau C.Y., Qureshi A.K. Azithromycin versus doxycycline for genital chlamydial infections: a meta-analysis of randomized clinical trials. Sex Transm Dis 2002, 29:497-502.
41. Moodley P., Wilkinson D., Connolly C., et al. Trichomonas vaginalis is associated with pelvic inflammatory disease in women infected with human immunodeficiency virus. Clin Infect Dis 2002, 34:519.
42. Centers for Disease Control and Prevention Sexually transmitted disease, trichomoniasis fact sheet 2012, CDC, Atlanta (GA), Available at:, Accessed June 21, 2013. http://www.cdc.gov/std/trichomonas/STDFact-Trichomoniasis.htm.
43. Laga M., Manoka A., Kivuvu M., et al. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS 1993, 7:95.
44. Grodstein F., Goldman M.B., Cramer D.W. Relation of tubal infertility to history of sexually transmitted diseases. Am J Epidemiol 1993, 137(5):577.
45. Zhang Z.F., Begg C.B. Is Trichomonas vaginalis a cause of cervical neoplasia? Results from a combined analysis of 24 studies. Int J Epidemiol 1994, 23:682.
46. Soper D.E., Bump R.C., Hurt W.G. Bacterial vaginosis and trichomoniasis vaginitis are risk factors for cuff cellulitis after abdominal hysterectomy. Am J Obstet Gynecol 1990, 163:1016.
47. Cotch M.F., Pastorek J.G., Nugent R.P., et al. Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group. Sex Transm Dis 1997, 24:353.
48. Krieger J.N., Tam M.R., Stevens C.E., et al. Diagnosis of trichomoniasis. Comparison of conventional wet-mount examination with cytologic studies, cultures, and monoclonal antibody staining of direct specimens. JAMA 1988, 259:1223.
49. Centers for Disease Control and Prevention Primary and secondary syphilis-United States, 1998. MMWR Morb Mortal Wkly Rep 1999, 48:873.
50. Centers for Disease Control and Prevention. 2011 Sexually transmitted disease surveillance- syphilis. Available at: Accessed February 28, 2013. http://www.cdc.gov/std/Syphilis2011/default.htm.
51. Wong W., Chaw K., Kent C.K., et al. Risk factors for early syphilis among gay and bisexual men seen in an STD clinic in San Francisco, 2002-2003. Sex Transm Dis 2005, 32:458.
52. Centers for Disease Control and Prevention Congenital syphilis-United States, 2002. MMWR Morb Mortal Wkly Rep 2003, 53:716.
53. Centers for Disease Control and Prevention Transmission of primary and secondary syphilis by oral sex-Chicago, Illinois, 1998-2002. MMWR Morb Mortal Wkly Rep 2004, 53:966.
54. Hook E.W., Marra C.M. Acquired syphilis in adults. NEngl J Med 1992, 326:1060.
55. Peterman T.A., Kahn R.H., Ciesielski C.A., et al. Misclassification of the stages of syphilis: implications for surveillance. Sex Transm Dis 2005, 32:144.
56. Centers for Disease Control and Prevention. Sexually transmitted diseases -syphilis-CDC fact sheet. Available at: Accessed February 28, 2013. http://www.cdc.gov/std/syphilis/STDFact-Syphilis-detailed.htm.
57. Centers for Disease Control and Prevention. 2008 Sexually Transmitted Disease Surveillance. Table33: Primary and secondary syphilis reported cases and rates per 100,000 population by age group and sex: United States, 2004-2008. Available at: Accessed February 28, 2013. http://www.cdc.gov/std/stats08/tables/33.htm.
58. Centers for Disease Control and Prevention Congenital syphilis-United States, 2003-2008. MMWR Morb Mortal Wkly Rep 2010, 59:413.
59. American Academy of Pediatrics Syphilis. Red Book: 2012 Report of the Committee on Infectious Diseases 2012, vol. 29:690. American Academy of Pediatrics, Elk Grove Village (IL).
60. Lai W., Chen C.Y., Morse S.A., et al. Increasing relative prevalence of HSV-2 infection among men with genital ulcers from a mining community in South Africa. Sex Transm Infect 2003, 79:202.
61. O'Farrell N. Increasing prevalence of genital herpes in developing countries: implications for heterosexual HIV transmission and STI control programs. Sex Transm Infect 1999, 75:377.
62. Plummer F.A., Simonson J.N., Cameron D.W., et al. Co-factors in male to female transmission of HIV. JInfect Dis 1991, 163:233.
63. Gelfanova V., Humphreys T.L., Spinola S.M. Characterization of Haemophilus ducreyi-specific T-cell lines from lesions of experimentally infected human subjects. Infect Immun 2001, 69:4224.
64. Dillon S.M., Cummings M., Rajagopalan S., et al. Prospective analysis of genital ulcer disease in Brooklyn, New York. Clin Infect Dis 1997, 24:945.
65. Mertz K.J., Weiss J.B., Webb R.M., et al. An investigation of genital ulcers in Jackson, Mississippi with use of a multiplex polymerase chain reaction assay: high prevalence of chancroid and human immunodeficiency virus infection. JInfect Dis 1998, 178:1060.
66. Hart G. Venereal disease in a war environment: incidence and management. Med J Aust 1975, 1:808.
67. Cope L.D., Lumbley S., Latimer J.L., et al. Adiffusible cytotoxin of Haemophilus ducreyi. Proc Natl Acad Sci USA 1997, 94:4056.
68. Wharton M., Chorba T.L., Vogt R.L., et al. Case definitions for public health surveillance. MMWR Morb Mortal Wkly Rep 1990, 39:1.
69. Mabey D., Richens J. Sexually transmitted infections. Manson's tropical diseases 2003, 444. Elsevier Science, Edinburgh (United Kingdom). G.C. Cook, A. Zumla (Eds.).
70. Riedner G., Todd J., Rusizoka M., et al. Possible reasons for an increase in the proportion of genital ulcers due to herpes simplex virus from a cohort of female bar workers in Tanzania. Sex Transm Infect 2007, 83:91.
71. DiCarlo R.P., Martin D.H. The clinical diagnosis of genital ulcer disease in men. Clin Infect Dis 1997, 25:292.
72. Xu F., Sternberg M.R., Kottiri B.J., et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA 2006, 296:964.
73. Langenberg A.G., Corey L., Ashley R.L., et al. Aprospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group. NEngl J Med 1999, 341:1432.
74. Freeman E., Weiss H.A., Glynn J.R., et al. Herpes simplex virus 2 infections increase HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS 2006, 20:73-83.
75. Gupta R., Warren T., Wald A. Genital herpes. Lancet 2007, 370:2127.
76. Corey L., Adams H.G., Brown Z.A., et al. Genital herpes simplex virus infections: clinical manifestations, course, and complications. Ann Intern Med 1983, 98:958.
77. American College of Obstetricians and Gynecologists Gynecological herpes simplex virus infections. ACOG Practice Bulletin No. 57. Obstet Gynecol 2004, 104:1111-1117.
78. Guerry S.L., Bauer H.M., Klausner J.D., et al. Recommendations for the selective use of herpes simplex virus type 2 serological tests. Clin Infect Dis 2005, 40:38-45.
79. Cernik C., Gallina K., Brodell R.T. The treatment of herpes simplex infections: an evidence-based review. Arch Intern Med 2008, 168:1137.
80. Perry C.M., Wagstaff A.J. Famciclovir. A review of its pharmacological properties and therapeutic efficacy in herpesvirus infections. Drugs 1995, 50:396.
81. Perry C.M., Faulds D. Valacyclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in herpesvirus infections. Drugs 1996, 52:754.
82. Diaz-Mitoma F., Sibbald R.G., Shafran S.D., et al. Oral famciclovir for the suppression of recurrent genital herpes: a randomized controlled trial. Collaborative Famciclovir Genital Herpes Research Group. JAMA 1998, 280:887-892.
83. Behets F.M., Andriamiadana J., Randrianasolo D., et al. Chancroid, primary syphilis, genital herpes and lymphogranuloma venereum in Antananarivo, Madagascar. JInfect Dis 1999, 180:1382.
84. Scieux C., Barnes R., Bianchi A., et al. Lymphogranuloma venereum: 27 cases in Paris. JInfect Dis 1989, 160:662.
85. Blank S., Schillinger J.A., Harbatkin D. Lymphogranuloma venereum in the industrialized world. Lancet 2005, 365:1607.
86. White J.A. Manifestations and management of lymphogranuloma venereum. Curr Opin Infect Dis 2009, 22:57.
87. Martin-Iguacel R., Libre J.M., Nielson H., et al. Lymphogranuloma venereum proctocolitis: a silent endemic disease in men who have sex with men in industrialized countries. Eur J Clin Microbiol Infect Dis 2010, 29:917.
88. Van der Bij A.K., Spaargaren J., Morré S.A., et al. Diagnostic and clinical implications of anorectal lymphogranuloma venereum in men who have sex with men: a retrospective case-control study. Clin Infect Dis 2006, 42:186.
89. Ward H., Martin I., Macdonald N., et al. Lymphogranuloma venereum in the United Kingdom. Clin Infect Dis 2007, 44:26.
90. Bedi R., Scully C. Tropical oral health. Manson's tropical diseases 2003, 521. Elsevier Science, Edinburgh (United Kingdom). G.C. Cook, A. Zumla (Eds.).
91. Hampton T. Lymphogranuloma venereum targeted: those at risk identified; diagnostic test developed. JAMA 2006, 295:2592.
92. Bachmann L.H., Johnson R.E., Cheng H., et al. Nucleic acid amplification tests for diagnosis of Neisseria gonorrhoeae and Chlamydia trachomatis rectal infections. JClin Microbiol 2010, 48:1827.
93. O'Farrell N., Hoosen A.A., Coetzee K., et al. Genital ulcer disease in women in Durban, South Africa. Genitourin Med 1991, 67:327.
94. Kharsamy AB, Mohabeer Y, Goga R, etal. Aetiology of genital ulcer disease and HIV infection among men attending a STD clinic. 13th Meeting of the International Society for Sexually Transmitted Diseases Research, Abstract 533. Denver, July 11-14, 1999.
95. Govender D., Naidoo K., Chetty R. Granuloma inguinale (donovanosis). An unusual cause of otitis media and mastoiditis in children. Am J Clin Pathol 1997, 108:510.
96. O'Farrell N. Donovanosis. Sex Transm Infect 2002, 78:452.
97. O'Farrell N., Moi H. European Guidelines for the management of donovanosis. Int J STD AIDS 2010, 21(9):609.
98. Beutner K.R. Nongenital human papillomavirus infections. Clin Lab Med 2000, 20:423.
99. deSanjose S., Quint W.G., Alemany L., et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol 2010, 11:1048.
100. de Sanjose S., Diaz M., Castellsague X., et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 2007, 7:453.
101. Center for Disease Control and Prevention Genital HPV infection-CDC fact sheet 2004, CDC, Atlanta (GA).
102. Center for Disease Control and Prevention, Workowski K.A., Berman S.M. Sexually transmitted disease treatment guidelines, 2006. MMWR Recomm Rep 2006, 55:1.
103. Ho G.Y., Bierman R., Beardsley L., et al. Natural history of cervicovaginal papillomavirus infection in young women. NEngl J Med 1998, 338:423.
104. Winer R.L., Lee S.K., Hughes J.P., et al. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol 2003, 157:218.
105. Doorbar J. Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci (Lond) 2006, 110:525.
106. Center for Disease Control and Prevention. Incidence, prevalence, and cost of sexually transmitted infections in the United States, February 2013. Available at: Accessed February 28, 2013. http://www.cdc.gov/std/stats/STI-Estimates-Fact-Sheet-Feb-2013.pdf.
107. Dohil M.A., Lin P., Lee J., et al. The epidemiology of Molluscum contagiosum in children. JAm Acad Dermatol 2006, 54:47.
108. Koopman R.J., van Merrienboer F.C., Vreden S.G., et al. Molluscum contagiosum: a marker for advanced HIV infection. Br J Dermatol 1992, 126:528.
109. Kakourou T., Zacharides A., Anastasiou T., et al. Molluscum contagiosum in Greek children: a case series. Int J Dermatol 2005, 44:221-223.
110. Braue A., Ross G., Varigos G., et al. Epidemiology and impact of childhood Molluscum contagiosum: a case series and critical review of the literature. Pediatr Dermatol 2005, 22:287.
111. Center for Disease Control and Prevention. Clinical information: Molluscum contagiosum. Available at: Accessed February 28, 2013. http://www.cdc.gov/ncidod/dvrd/molluscum/clinical_overview.htm.
112. Anderson A.L., Chaney E. Pubic Lice (Phthirus pubis): history, biology and treatment vs. knowledge and beliefs of US college students. Int J Environ Res Public Health 2009, 6(2):592.
113. Rick F.M., Rocha G.C., Dittmar K., et al. Crab louse infestation in pre-Columbian America. JParasitol 2002, 88(6):1266.
114. Galiczynski E.M., Elston D.M. What's eating you? Pubic lice (Phthirus pubis). Cutis 2008, 81:109.
115. Letau L.A. Nosocomial transmission and infection control aspects of parasitic and ectoparasitic diseases. Part III. Ectoparasites/summary and conclusions. Infect Control Hosp Epidemiol 1991, 12:179.
116. Varela J.A., Otero L., Espinosa E., et al. Phthirus pubis in a sexually transmitted diseases unit. Sex Transm Dis 2003, 30(4):292.
117. Stone S.P., Goldfarb J.N., Bacelieri R.E. Scabies, other mites and pediculosis. Fitzpatrick's dermatology in general medicine 2008, 2029. McGraw-Hill, New York. K. Wolf, L.A. Goldsmith, S.I. Katz (Eds.).
118. Burkhart C.N., Burkhart C.G. Oral ivermectin therapy for Phthiriasis palpebrum. Arch Ophthalmol 2000, 118:134.
119. Ikeda N., Nomoto H., Hayasaka S., et al. Phthirus pubis infestation of the eyelashes and scalp hairs in a girl. Pediatr Dermatol 2003, 20:356.
120. Lin J.S., Whitlock E., O'Connor E., et al. Behavioral counseling to prevent sexually transmitted infections: a systematic review for the U.S. preventive services task force. Ann Intern Med 2008, 149:497-508.
121. Dilley J.W., Woods W.J., Loeb L., et al. Brief cognitive counseling with HIV testing to reduce sexual risk among men who have sex with men: results from a randomized controlled trial using paraprofessional counselors. JAcquir Immune Defic Syndr 2007, 44:569.
122. Okanlawon F.A., Asuzu M.C. Effect of peer education intervention on secondary school adolescents' reproductive health knowledge in Saki, Nigeria. Afr J Med Med Sci 2011, 40(4):353-360.
123. World Health Organization & The Department of Reproductive Health and Research, Johns Hopkins Bloomberg School of Public Health/Center for Communication Programs, INFO Project Family planning: a global handbook for providers 2007, CCP and WHO, Baltimore (MD); Geneva (Switzerland).
124. Gostin L.O., Hankins C.A. Male circumcision as an HIV prevention strategy in Sub-Saharan Africa: sociolegal barriers. JAMA 2008, 300:2539.
125. Gray R.H., Kigozi G., Serwadda D., et al. The effects of male circumcision on female partners' genital tract symptoms and vaginal infections in a randomized trial in Rakai, Uganda. Am J Obstet Gynecol 2009, 200:42.e1.